These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 14523792)

  • 1. Oxaliplatin-based combined-modality therapy for rectal cancer.
    Minsky BD
    Semin Oncol; 2003 Aug; 30(4 Suppl 15):26-33. PubMed ID: 14523792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined-modality therapy of rectal cancer with oxaliplatin-based regimens.
    Minsky BD
    Clin Colorectal Cancer; 2004 Jun; 4 Suppl 1():S29-36. PubMed ID: 15212703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Addition of weekly oxaliplatin to standard preoperative chemoradiation for locally advanced rectal cancer.
    Aschele C; Lonardi S
    J Clin Oncol; 2007 Feb; 25(5):602-3; author reply 603. PubMed ID: 17290071
    [No Abstract]   [Full Text] [Related]  

  • 4. Combined-modality therapy of rectal cancer with irinotecan-based regimens.
    Minsky BD
    Oncology (Williston Park); 2004 Dec; 18(14 Suppl 14):49-55. PubMed ID: 15685836
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 5-fluorouracil and weekly oxaliplatin combined with radiotherapy for locally advanced rectal cancer: surgical complications and long-term results.
    Pucciarelli S; Urso E; DeSalvo GL; Aschele C; Friso ML; Rugge M; Toppan P; Bruttocao A; Fabris G; Ferraro B; Lonardi S; Frego M; Finco C; Lise M; Nitti D
    Arch Med Res; 2006 Oct; 37(7):860-5. PubMed ID: 16971226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of neoadjuvant chemotherapy with oxaliplatin, 5-fluorouracil, and levofolinate for T3 or T4 stage II/III rectal cancer: the FACT trial.
    Koike J; Funahashi K; Yoshimatsu K; Yokomizo H; Kan H; Yamada T; Ishida H; Ishibashi K; Saida Y; Enomoto T; Katsumata K; Hisada M; Hasegawa H; Koda K; Ochiai T; Sakamoto K; Shiokawa H; Ogawa S; Itabashi M; Kameoka S
    Cancer Chemother Pharmacol; 2017 Mar; 79(3):519-525. PubMed ID: 28150022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rectal cancer: integrating oxaliplatin into chemoradiation studies.
    Ryan DP
    Oncology (Williston Park); 2000 Dec; 14(12 Suppl 11):38-41. PubMed ID: 11204662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phase II Trial of Preoperative Radiation With Concurrent Capecitabine, Oxaliplatin, and Bevacizumab Followed by Surgery and Postoperative 5-Fluorouracil, Leucovorin, Oxaliplatin (FOLFOX), and Bevacizumab in Patients With Locally Advanced Rectal Cancer: 5-Year Clinical Outcomes ECOG-ACRIN Cancer Research Group E3204.
    Landry JC; Feng Y; Prabhu RS; Cohen SJ; Staley CA; Whittington R; Sigurdson ER; Nimeiri H; Verma U; Benson AB
    Oncologist; 2015 Jun; 20(6):615-6. PubMed ID: 25926352
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multidisciplinary management of resectable rectal cancer.
    Minsky BD
    Oncology (Williston Park); 1996 Nov; 10(11):1701-8, 1713-4; discussion 1714-18. PubMed ID: 8953589
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Complete pathologic response following preoperative chemoradiation therapy for middle to lower rectal cancer is not a prognostic factor for a better outcome.
    Pucciarelli S; Toppan P; Friso ML; Russo V; Pasetto L; Urso E; Marino F; Ambrosi A; Lise M
    Dis Colon Rectum; 2004 Nov; 47(11):1798-807. PubMed ID: 15622571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemoradiation with raltitrexed and oxaliplatin in preoperative treatment of stage II-III resectable rectal cancer: Phase I and II studies.
    Gambacorta MA; Valentini V; Coco C; Morganti AG; Smaniotto D; Miccichè F; Mantini G; Barbaro B; Garcia-Vargas JE; Magistrelli P; Picciocchi A; Cellini N
    Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):139-48. PubMed ID: 15337549
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined modality therapy of resectable rectal cancer: current approaches.
    Minsky BD
    Tech Coloproctol; 2004 Aug; 8(2):67-76. PubMed ID: 15309641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk-adapted adjuvant chemotherapy after concomitant fluoropyrimidine-radiotherapy neoadjuvant treatment for patients with resectable cT3-4 or N+ rectal cancer.
    Sastre J; Custodio A; Sanchez JC; Ortega L; Rodriguez L; Puente J; Corona J; Alfonso R; de las Heras M; Dıaz-Rubio E
    Anticancer Drugs; 2011 Feb; 22(2):185-90. PubMed ID: 21218606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phase II study of neoadjuvant concurrent chemioradiotherapy with oxaliplatin-containing regimen in locally advanced rectal cancer.
    Turitto G; Panelli G; Frattolillo A; Auriemma A; de Luna FS; Cione G; De Angelis CP; Muto P; Iaffaioli RV
    Front Biosci; 2006 May; 11():1275-9. PubMed ID: 16368513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oxaliplatin added to fluorouracil-based preoperative chemoradiotherapy and postoperative chemotherapy of locally advanced rectal cancer (the German CAO/ARO/AIO-04 study): final results of the multicentre, open-label, randomised, phase 3 trial.
    Rödel C; Graeven U; Fietkau R; Hohenberger W; Hothorn T; Arnold D; Hofheinz RD; Ghadimi M; Wolff HA; Lang-Welzenbach M; Raab HR; Wittekind C; Ströbel P; Staib L; Wilhelm M; Grabenbauer GG; Hoffmanns H; Lindemann F; Schlenska-Lange A; Folprecht G; Sauer R; Liersch T;
    Lancet Oncol; 2015 Aug; 16(8):979-89. PubMed ID: 26189067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A phase II study of neoadjuvant chemoradiotherapy with oxaliplatin and capecitabine for rectal cancer.
    Zhao L; Bai C; Shao Y; Guan M; Jia N; Xiao Y; Qiu H; Zhang F; Yang T; Zhong G; Chen S
    Cancer Lett; 2011 Nov; 310(2):134-9. PubMed ID: 21782322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multicenter phase II trial of chemoradiation with oxaliplatin for rectal cancer.
    Rödel C; Liersch T; Hermann RM; Arnold D; Reese T; Hipp M; Fürst A; Schwella N; Bieker M; Hellmich G; Ewald H; Haier J; Lordick F; Flentje M; Sülberg H; Hohenberger W; Sauer R
    J Clin Oncol; 2007 Jan; 25(1):110-7. PubMed ID: 17194912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Response in a case of advanced rectal cancer treated by chemoradiation with S-1/oxaliplatin].
    Saito M; Ishi Y; Kikuchi D; Yamada M; Takenoshita S
    Gan To Kagaku Ryoho; 2011 Jul; 38(7):1217-9. PubMed ID: 21772116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Oxaliplatin and preoperative chemoradiotherapy in rectal cancer].
    Ortholan C; Francois E; Follana P; Gérard JP
    Bull Cancer; 2006 Feb; 93 Suppl 1():S51-8. PubMed ID: 16483946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Integration of novel agents into combined-modality treatment for rectal cancer patients.
    Rödel C; Sauer R
    Strahlenther Onkol; 2007 May; 183(5):227-35. PubMed ID: 17497093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.